ATRX mutations were initially detected in small CM series subjected to comprehensive genetic analyses (identified in ~20–60% of cases) [32,34] and later validated in a relatively large CM series (found in 25% of cases) [27]. The gene discussed is ATRX; the disease is cutaneous mastocytosis.